Join to View Full Profile
330 Brookline Ave.Boston, MA 02215
Dr. Grossman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2012 - 2015
The Warren Alpert Medical School of Brown UniversityClass of 2012
Certifications & Licensure
MA State Medical License 2016 - 2023
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastat...Breelyn A Wilky, Gary K Schwartz, Michael S Gordon, Anthony B El-Khoueiry, Andrea J Bullock
Journal of Clinical Oncology. 2025-01-27 - 5 citationsBotensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy.Dhan Chand, David A Savitsky, Shanmugarajan Krishnan, Gabriel Mednick, Chloe Delepine
Cancer Discovery. 2024-12-02 - 17 citationsBotensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial.Andrea J Bullock, Benjamin L Schlechter, Marwan G Fakih, Apostolia M Tsimberidou, Joseph E Grossman
Nature Medicine. 2024-09-01
Authored Content
- Organoid sensitivity correlates with therapeutic response in patients with pancreatic cancerFebruary 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
